title: The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.
abstract: B cell development is controlled by a series of checkpoints that ensure that the immunoglobulin (Ig)-encoding genes produce a functional B cell receptor (BCR) and antibodies. As part of this process, recombination-activating gene (Rag) proteins regulate the in-frame assembly of the Ig-encoding genes. The BCR consists of Ig proteins in complex with the immunoreceptor tyrosine-based activation motif (ITAM)-containing Igalpha and Igbeta chains. Whereas the activation of the tyrosine kinases Src and Syk is essential for BCR signaling, the pathways that act downstream of these kinases are incompletely defined. Previous work has revealed a key role for the p110delta isoform of phosphatidylinositol 3-kinase (PI3K) in agonist-induced BCR signaling; however, early B cell development and mature B cell survival, which depend on agonist-independent or "tonic" BCR signaling, are not substantially affected by a deficiency in p110delta. Here, we show that p110alpha, but not p110beta, compensated in the absence of p110delta to promote early B cell development in the bone marrow and B cell survival in the spleen. In the absence of both p110alpha and p110delta activities, pre-BCR signaling failed to suppress the production of Rag proteins and to promote developmental progression of B cell progenitors. Unlike p110delta, however, p110alpha did not contribute to agonist-induced BCR signaling. These studies indicate that either p110alpha or p110delta can mediate tonic signaling from the BCR, but only p110delta can contribute to antigen-dependent activation of B cells.
authors.affiliation: 1Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.
authors.forename: Faruk
authors.initials: F
authors.lastname: Ramadani
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Bolland
authors.forename: Fabien
authors.initials: F
authors.lastname: Garcon
authors.forename: Juliet L
authors.initials: JL
authors.lastname: Emery
authors.forename: Bart
authors.initials: B
authors.lastname: Vanhaesebroeck
authors.forename: Anne E
authors.initials: AE
authors.lastname: Corcoran
authors.forename: Klaus
authors.initials: K
authors.lastname: Okkenhaug
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology* / Q000276:immunology; D015153:Blotting, Western; D058534:Class I Phosphatidylinositol 3-Kinases; D017931:DNA Primers / Q000235:genetics; D004268:DNA-Binding Proteins / Q000378:metabolism; D005434:Flow Cytometry; D020869:Gene Expression Profiling; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D051379:Mice; D008817:Mice, Mutant Strains; D019869:Phosphatidylinositol 3-Kinases / Q000276:immunology*; D054420:Pre-B Cell Receptors / Q000378:metabolism*; D015398:Signal Transduction / Q000276:immunology*; D013047:Specific Pathogen-Free Organisms
chemical_list: D017931:DNA Primers; D004268:DNA-Binding Proteins; D054420:Pre-B Cell Receptors; C499308:Rag2 protein, mouse; D019869:Phosphatidylinositol 3-Kinases; C509622:1-phosphatidylinositol 3-kinase p110 subunit, mouse; D058534:Class I Phosphatidylinositol 3-Kinases